Samlyn Capital »

Janux Therapeutics shares owned by Samlyn Capital

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Samlyn Capital from 13F filings

Historical chart of Samlyn Capital investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Samlyn Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Samlyn Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $11M 296k 37.65

More positions owned by Samlyn Capital

First Solar (FSLR)
Lpl Financial Holdings (LPLA)
Meta Platforms Cl A (META)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Core & Main Cl A (CNM)
Natera (NTRA)
Kaspi Kz Jsc Sponsored Ads (KSPI)
Planet Fitness Cl A (PLNT)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Large Cap Etf (VV)
Advanced Micro Devices (AMD)
Anheuser Busch Inbev Sa Sponsored Adr (BUD)
Draftkings Com Cl A (DKNG)
Take-Two Interactive Software (TTWO)

View all positions for Samlyn Capital

Top funds holding Janux Therapeutics

RA Capital Management
FMR
OrbiMed Advisors
BVF
Adage Capital Partners GP
Citadel Advisors
Henderson Group
BlackRock
Vanguard Group
Cormorant Asset Management
Lord, Abbett & Co
Geode Capital Management
Avidity Partners Management
Goldman Sachs Group
Samlyn Capital

View all funds holding Janux Therapeutics